Dental complications of cytotoxic therapy in Hodgkin's disease--a case report.
A case of trigeminal zoster in a patient with disseminated Hodgkin's disease is described. Although one case of maxillary tooth loss in a comparable patient has previously been recorded, this is the first report of mandibular tooth loss. The aetiological significance of Beomycin and I-(2-chloroethyl)-3-cyclohexyl-I-nitrosourea (C.C.N.U.) is discussed and an hypothesis for post-zoster tooth exfoliation is suggested.
D000328:Adult; D001761:Bleomycin / Q000009:adverse effects; D005260:Female; D006562:Herpes Zoster / Q000209:etiology; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D008130:Lomustine / Q000009:adverse effects; D008336:Mandibular Diseases / Q000209:etiology*; D010019:Osteomyelitis / Q000209:etiology*; D010523:Peripheral Nervous System Diseases / Q000209:etiology; D014080:Tooth Exfoliation / Q000209:etiology*; D014276:Trigeminal Nerve
D001761:Bleomycin; D008130:Lomustine